Work

Toward Objective, Continuous Symptom Assessment in Myasthenia Gravis using Digital Health Technology

Year: 2026

Type: article

Abstract: To develop and validate a multi-modal digital health technology for remote monitoring of disease symptoms in myasthenia gravis (MG). MG is a chronic autoimmune neuromuscular disease characterized by muscle weakness and fatigue. MG symptoms are typically evaluated by neuromuscular experts through in-person neurological examinations that are time-consuming, require disease expertise, and capture only a snapshot in time. We developed a multi-modal digital health technology (DHT) called BioDigit MG, for monitoring MG symptoms.

Source: Neurotherapeutics

DOI: 10.1016/j.neurot.2026.e00997

Authors: Ashkan Vaziri, Ram Kinker Mishra, Ilkay Yildiz Potter, Amanda Guidon

Institution: BioSensics (United States)

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,900